Javier Garces-Eisele
Overview
Explore the profile of Javier Garces-Eisele including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Olivares-Gazca J, Priesca-Marin J, Ojeda-Laguna M, Garces-Eisele J, Soto-Olvera S, Palacios-Alonso A, et al.
Rev Invest Clin
. 2020 Jun;
72(3):159-164.
PMID: 32584322
Background: The ideal treatment of coronavirus disease (COVID)-19 has yet to be defined, but convalescent plasma (CoPla) has been successfully employed. Objective: The objective of the study was to study...
2.
Vallejo-Villalobos M, Leon-Pena A, Leon-Gonzalez M, Nunez-Cortes A, Olivares-Gazca J, Valdes-Tapia P, et al.
Indian J Hematol Blood Transfus
. 2017 Aug;
33(3):375-379.
PMID: 28824240
Activated protein C resistance (aPCR) phenotypes represent around 20% of the laboratory findings in Mexican Mestizos having suffered thrombosis and displaying clinical markers of thrombophilia. In a single institution for...
3.
Reyes-Nunez V, Galo-Hooker E, Perez-Romano B, Duque R, Ruiz-Arguelles A, Garces-Eisele J
Cytometry B Clin Cytom
. 2017 Mar;
94(1):172-181.
PMID: 28316130
Background: The aim of this work was to simultaneously use multiplex ligation-dependent probe amplification (MLPA) assay and flow cytometric DNA ploidy analysis (FPA) to detect aneuploidy in patients with newly...
4.
Cuervo-Sierra J, Jaime-Perez J, Martinez-Hernandez R, Garcia-Sepulveda R, Sanchez-Cardenas M, Gomez-Almaguer D, et al.
Arch Med Res
. 2016 Jul;
47(3):172-9.
PMID: 27373815
Background And Aims: FLT3-ITD mutations in acute myeloid leukemia (AML) are associated with a poor prognosis. In Latin America, little epidemiological data exist about these mutations and their influence on...
5.
Ruiz-Delgado G, Hernandez-Reyes J, Gonzalez-Ramirez M, Martagon-Herrera N, Garces-Eisele J, Ruiz-Arguelles A, et al.
Gac Med Mex
. 2015 Nov;
151(5):582-7.
PMID: 26526471
Donor-derived malignancies after allogeneic hematopoietic stem cell transplantation and after solid organ transplantation are considered as rare diseases. We have prospectively searched for donor cell leukemia in a 12-year period,...
6.
Labastida-Mercado N, Galindo-Becerra S, Garces-Eisele J, Colunga-Pedraza P, Guzman-Olvera V, Reyes-Nunez V, et al.
Hematol Oncol Stem Cell Ther
. 2015 Feb;
8(1):16-21.
PMID: 25637689
Context And Objective: By using molecular markers, it is possible to gain information on both the classification and etiopathogenesis of chronic myeloproliferative neoplasias (MPN). Methods: In a group of 27...
7.
Rego E, Kim H, Ruiz-Arguelles G, Undurraga M, Uriarte M, Jacomo R, et al.
Blood
. 2013 Jan;
121(11):1935-43.
PMID: 23319575
Thanks to modern treatment with all-trans retinoic acid and chemotherapy, acute promyelocytic leukemia (APL) is now the most curable type of leukemia. However, this progress has not yielded equivalent benefit...
8.
Ruiz-Arguelles G, Garces-Eisele J, Camacho-Alarcon C, Reyes-Nunez V, Moncada-Gonzalez B, Valdes-Tapia P, et al.
Clin Appl Thromb Hemost
. 2012 Jul;
19(6):689-92.
PMID: 22751911
Introduction: The sticky platelet syndrome (SPS) seems to be a common cause of thrombosis, although no molecular substrate to explain platelet hyperaggregability has been found. Objective: To analyze an association...
9.
Garces-Eisele J
Hematology
. 2012 Apr;
17 Suppl 1:S66-8.
PMID: 22507783
The prognostic significance of minimal residual disease (MRD) has been demonstrated for a variety of hematologic malignancies. PCR based assays are among the most important methods for identifying MRD. They...
10.
Rego E, Kim H, Ruiz-Arguelles G, Uriarte M, Jacomo R, Gutierrez-Aguirre H, et al.
Hematology
. 2012 Apr;
17 Suppl 1:S36-8.
PMID: 22507775
Objectives: Several clinical trials conducted in Europe and US reported favorable outcomes of patients with APL treated with the combination of all trans retinoic acid (ATRA) and anthracyclines. Nevertheless, the...